STXE 400 CONS.+ MAT.PR EO/ CH0009138824
YY3N2024-06-10 5:50:00 PM | Chg. -8.16 | Open | High | Low | Previous Close |
---|---|---|---|---|---|
805.17XXP | -1.00% | 804.37 | 805.56 | 794.24 | 813.33 |
GlobeNewswire
6:00 AM
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
Newsfile Corp
5:22 AM
"Winds of Change" Celebrating Kazakhstan's National Parks at The Canvas 3.0 Exhibition June 8th - Ju...
GlobeNewswire
5:16 AM
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared g...
GlobeNewswire
4:50 AM
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover...
GlobeNewswire
4:19 AM
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
GlobeNewswire
3:00 AM
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been F...
GlobeNewswire
3:00 AM
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fi...
GlobeNewswire
2:00 AM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before ...
GlobeNewswire
2:00 AM
ROSEN, A LONGSTANDING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel...
GlobeNewswire
1:19 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities...